GenKOre

Main Focus
In vivo gene-editing therapy

Company Stage
Pre-clinical

Technology | Tool
Hypercompact TaRGET system

Funding Stage
Series A

Location
South Korea

Website
www.genkore.com

GenKOre

Your Latest CMN News

Webinar

Enhancing T Cell Function for Cancer immunotherapy...

Mar. 20, 2023

Read more about the webinar - Enhancing T Cell Function for Cancer immunotherapy With CRISPR

CMN Weekly (17 March 2023) - Your Weekly CRISPR...

Mar. 17, 2023

Some of the best links we picked up around the internet

Intellia Therapeutics Gets FDA Green Light to...

Mar. 15, 2023

Intellia Therapeutics recently announced that the FDA has cleared an Investigational New Drug application for NTLA-2002, a single-dose in vivo CRISPR...

CMN Weekly (10 March 2023) - Your Weekly CRISPR...

Mar. 10, 2023

Some of the best links we picked up around the internet

Cas12a chRDNA - A Novel Approach to Gene-Editing...

Mar. 6, 2023

Founded in 2011, Caribou Biosciences is developing novel allogeneic CAR-T cell and CAR-natural killer cell therapies to treat cancer. The UC Berkeley...

CMN Weekly (3 March 2023) - Your Weekly CRISPR...

Mar. 3, 2023

Some of the best links we picked up around the internet

GenKOre

Tags

Related News and Updates

Job Opportunities

Clinical Trials

Pre-clinical Trials

Stocks and Markets

Diseases

Webinar

Your Latest CMN News